PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 201 filers reported holding PTC THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,292,274 | -0.7% | 102,288 | +80.3% | 0.00% | 0.0% |
| Q2 2023 | $2,307,412 | -39.6% | 56,735 | -28.1% | 0.00% | -40.0% |
| Q1 2023 | $3,819,833 | +49.5% | 78,857 | +17.8% | 0.01% | +25.0% |
| Q4 2022 | $2,555,901 | -99.9% | 66,961 | -4.2% | 0.00% | -33.3% |
| Q3 2022 | $3,510,084,000 | +161.0% | 69,922 | +108.3% | 0.01% | +200.0% |
| Q2 2022 | $1,344,734,000 | +27.8% | 33,568 | +19.0% | 0.00% | +100.0% |
| Q1 2022 | $1,052,179,000 | +81.4% | 28,201 | +93.6% | 0.00% | 0.0% |
| Q4 2021 | $580,044,000 | +24.5% | 14,563 | +16.3% | 0.00% | 0.0% |
| Q3 2021 | $465,758,000 | +325.3% | 12,517 | +383.1% | 0.00% | – |
| Q2 2021 | $109,522,000 | -70.7% | 2,591 | -67.2% | 0.00% | -100.0% |
| Q1 2021 | $374,207,000 | -33.8% | 7,903 | -14.7% | 0.00% | 0.0% |
| Q4 2020 | $565,260,000 | -17.3% | 9,262 | -36.6% | 0.00% | 0.0% |
| Q3 2020 | $683,158,000 | +101.3% | 14,613 | +118.5% | 0.00% | 0.0% |
| Q2 2020 | $339,349,000 | -90.0% | 6,688 | -91.2% | 0.00% | -85.7% |
| Q1 2020 | $3,382,063,000 | +717.0% | 75,814 | +779.6% | 0.01% | +600.0% |
| Q4 2019 | $413,971,000 | +18.0% | 8,619 | -16.9% | 0.00% | 0.0% |
| Q3 2019 | $350,713,000 | +10.1% | 10,370 | +46.5% | 0.00% | 0.0% |
| Q2 2019 | $318,600,000 | -29.8% | 7,080 | -41.3% | 0.00% | 0.0% |
| Q1 2019 | $454,014,000 | +1216.3% | 12,062 | +1100.2% | 0.00% | – |
| Q4 2018 | $34,492,000 | -71.4% | 1,005 | -60.8% | 0.00% | – |
| Q3 2018 | $120,461,000 | +84.3% | 2,563 | +32.2% | 0.00% | – |
| Q2 2018 | $65,369,000 | -72.1% | 1,938 | -77.6% | 0.00% | – |
| Q1 2018 | $234,231,000 | +66.0% | 8,656 | +2.3% | 0.00% | – |
| Q4 2017 | $141,079,000 | +67.6% | 8,458 | +111.2% | 0.00% | – |
| Q3 2017 | $84,172,000 | +7.9% | 4,005 | -5.9% | 0.00% | – |
| Q2 2017 | $77,994,000 | +1112.0% | 4,255 | +550.6% | 0.00% | – |
| Q1 2017 | $6,435,000 | -39.2% | 654 | -32.6% | 0.00% | – |
| Q4 2016 | $10,583,000 | -71.0% | 970 | -62.7% | 0.00% | – |
| Q3 2016 | $36,468,000 | +334.0% | 2,603 | +117.5% | 0.00% | – |
| Q2 2016 | $8,403,000 | -96.7% | 1,197 | -84.8% | 0.00% | -100.0% |
| Q4 2015 | $254,858,000 | +33.8% | 7,866 | +10.2% | 0.00% | – |
| Q3 2015 | $190,531,000 | +40.6% | 7,136 | +153.4% | 0.00% | – |
| Q2 2015 | $135,534,000 | +281.4% | 2,816 | +382.2% | 0.00% | – |
| Q1 2015 | $35,536,000 | -37.1% | 584 | -54.5% | 0.00% | – |
| Q3 2014 | $56,465,000 | +933.6% | 1,283 | +513.9% | 0.00% | – |
| Q2 2014 | $5,463,000 | +168.8% | 209 | +101.0% | 0.00% | – |
| Q1 2014 | $2,032,000 | -36.3% | 104 | -44.7% | 0.00% | – |
| Q4 2013 | $3,190,000 | – | 188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |